NIH award emphasizes long-term relationship, says AMRI

By Melissa Fassbender contact

- Last updated on GMT

AMRI will support DPI scientists advance early-stage NCATS drug discovery projects. (Image: iStock/Totojang)
AMRI will support DPI scientists advance early-stage NCATS drug discovery projects. (Image: iStock/Totojang)

Related tags: Economics

AMRI has received a 5-year federal contract award from the National Institutes of Health (NIH) under which it will provide drug substance development and manufacturing services.

The award, from NIH’s National Center for Advancing Translational Sciences (NCATS), supports the Division of Pre-Clinical Innovation’s (DPI) drug development programs.

The goal of the DPI is to advance collaborative research projects across pre-clinical phases of the translational science spectrum​,” Chris Conway, senior vice president, discovery, development and analytical services at AMRI told

The global contract research and manufacturing organization (CRO) will provide services related to process development, analytical development and small-scale GMP manufacture of small molecule drug candidates for preclinical trials.

Conway explained task order requests for proposals will be circulated amongst all contractors under a particular technical area each time new work is needed.

Investment in additional capacity is not anticipated at this point in time, he said.

The contract emphasizes our long-term relationship with the NIH – we’ve been working with the NIH for years with great success, and we are proud that our relationship with the NIH has grown and matured​,” added Conway.

Related news

Show more

Related products

show more

Seasonal Vaccine Manufacturing

Seasonal Vaccine Manufacturing

Baxter BioPharma Solutions | 19-Oct-2020 | Technical / White Paper

The production of seasonal vaccines, such as those for influenza, presents unique challenges to manufacturers due to the necessary time constraints resulting...

Liver Disease Capabilities

Liver Disease Capabilities

Q² Solutions | 01-Oct-2020 | Clinical Study

We integrate therapeutic insights, state-of-the-art technologies, best-in-class methods and quality systems to optimize NAFLD & NASH study design,...

CAR-T Cell Therapy

CAR-T Cell Therapy

Q² Solutions | 01-Sep-2020 | Clinical Study

Cell therapy involves the transfer of genetically altered cells into a patient. As a global central laboratory services organization, we provide testing...

Related suppliers

Follow us


View more